Nordea Investment Management AB Acquires New Stake in USANA Health Sciences Inc. (USNA)
Nordea Investment Management AB acquired a new position in USANA Health Sciences Inc. (NYSE:USNA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,092 shares of the company’s stock, valued at approximately $567,000.
Several other hedge funds also recently bought and sold shares of USNA. Norges Bank bought a new stake in USANA Health Sciences during the fourth quarter worth about $8,981,000. Acadian Asset Management LLC increased its stake in USANA Health Sciences by 1.8% in the first quarter. Acadian Asset Management LLC now owns 206,936 shares of the company’s stock worth $25,127,000 after buying an additional 3,614 shares in the last quarter. Parametrica Management Ltd bought a new stake in USANA Health Sciences during the first quarter worth about $410,000. Teachers Advisors Inc. increased its stake in USANA Health Sciences by 30.6% in the first quarter. Teachers Advisors Inc. now owns 87,383 shares of the company’s stock worth $10,610,000 after buying an additional 20,496 shares in the last quarter. Finally, Prudential Financial Inc. increased its stake in USANA Health Sciences by 48.3% in the first quarter. Prudential Financial Inc. now owns 31,317 shares of the company’s stock worth $3,802,000 after buying an additional 10,199 shares in the last quarter. 41.97% of the stock is owned by institutional investors.
USANA Health Sciences Inc. (NYSE:USNA) traded down 0.19% during mid-day trading on Friday, reaching $136.20. 44,958 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $136.16 and a 200-day moving average price of $123.82. USANA Health Sciences Inc. has a 12-month low of $92.00 and a 12-month high of $148.15. The stock has a market capitalization of $1.64 billion, a PE ratio of 17.95 and a beta of 1.16.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.05 by $0.02. The firm earned $258.50 million during the quarter, compared to analysts’ expectations of $256.66 million. USANA Health Sciences had a net margin of 10.07% and a return on equity of 34.15%. The company’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.92 earnings per share. Equities research analysts expect that USANA Health Sciences Inc. will post $8.10 EPS for the current year.
USNA has been the subject of a number of research analyst reports. DA Davidson lifted their price objective on shares of USANA Health Sciences from $135.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, July 28th. Zacks Investment Research raised shares of USANA Health Sciences from a “hold” rating to a “strong-buy” rating and set a $158.00 price objective for the company in a report on Saturday, July 30th. Two analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the stock. USANA Health Sciences presently has an average rating of “Buy” and a consensus price target of $149.11.
In other news, Director Gilbert A. Fuller sold 859 shares of the stock in a transaction on Monday, August 1st. The shares were sold at an average price of $137.07, for a total value of $117,743.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert Auciaux sold 2,317 shares of the stock in a transaction on Tuesday, August 23rd. The stock was sold at an average price of $138.79, for a total transaction of $321,576.43. Following the completion of the sale, the director now directly owns 2,317 shares of the company’s stock, valued at $321,576.43. The disclosure for this sale can be found here. 57.00% of the stock is currently owned by insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.